Vera Kadlecek

Safety and immunogenicity of a novel multivalent OspA-based vaccine candidate against Lyme borreliosis: a randomised, phase 1 study in healthy adults

Nicole Bézay, Romana Hochreiter, Vera Kadlecek et al. · The Lancet Infectious Diseases · 2023 · 37 citations

Vaccination, Vaccine Development, Vaccine Research +9

Optimisation of dose level and vaccination schedule for the VLA15 Lyme borreliosis vaccine candidate among healthy adults: two randomised, observer-blind, placebo-controlled, multicentre, phase 2 studies

Nicole Bézay, Laura Danielle Wagner, Vera Kadlecek et al. · The Lancet Infectious Diseases · 2024 · 25 citations

Vaccination, Vaccine Safety, Dose Level +8

Immunogenicity of the Inactivated Japanese Encephalitis Virus Vaccine IXIARO in Children From a Japanese Encephalitis Virus-endemic Region

Katrin Dubischar, Vera Kadlecek, Benjamin Sablan et al. · The Pediatric Infectious Disease Journal · 2017 · 21 citations

Safety and immunogenicity of an inactivated Vero cell_derived Japanese encephalitis vaccine (IXIARO®, JESPECT®) in a pediatric population in JE non-endemic countries: An uncontrolled, open-label phase 3 study

Tomáš Jelı́nek, Michael A. Cromer, Jakob P. Cramer et al. · Travel Medicine and Infectious Disease · 2018 · 21 citations · Full text

Safety of the Inactivated Japanese Encephalitis Virus Vaccine IXIARO in Children

Katrin Dubischar, Vera Kadlecek, Benjamin Sablan et al. · The Pediatric Infectious Disease Journal · 2017 · 18 citations